Literature DB >> 32329689

Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.

Qiong Wu1, Manlin Xiang1, Kun Wang1, Zhen Chen1, Lu Long1, Ya Tao1, Yunlai Liang1, Yahui Yan1, Zhiqiang Xiao2, Shiyang Qiu1, Bin Yi1.   

Abstract

BACKGROUND: Increasing evidence has shown that p62 plays an important role in tumorigenesis. However, relatively little is known about the association between p62 and tumor invasion and metastasis; in addition, its role in NPC (nasopharyngeal carcinoma, NPC) has been rarely investigated.
OBJECTIVE: To investigate the effect of p62 on tumorigenesis and metastasis in nasopharyngeal carcinoma.
METHODS: Western blotting, immunofluorescent staining and immunohistochemistry were used to evaluate p62 protein expression. Subsequently, cell viability, colony formation, migration, invasion and autophagy assays were performed. anti-p62 autoantibodies in sera were detected by ELISA. These data were correlated with clinicopathological parameters.
RESULTS: We confirmed that p62 was significantly up-regulated in NPC tissues. Furthermore, high expression of p62 was observed in NPC cell lines, and especially in the highly metastatic 5-8F cells. In vitro, down-regulation of p62 inhibited proliferation, clone forming ability, autophagy, migration, and invasion in 5-8F cells, whereas p62 overexpression resulted in the opposite effects in 6-10B cells. Moreover, we confirmed that p62 promotes NPC cell proliferation, migration, and invasion by activating ERK (extracellular signal-regulated kinase, ERK). Clinical analysis indicated that high p62 expression correlates with lymph node and distant metastasis (P<0.05). Serum anti-p62 autoantibodies were increased in NPC patients and levels were associated with metastasis.
CONCLUSION: Our data establish p62 targeting ERK as potential determinant in the NPC, which supplies a new pathway to treat NPC. Furthermore, p62 is a potential biomarker which might be closely related to the tumorigenesis and metastasis in NPC. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  EMT; ERK; Nasopharyngeal carcinoma; autoantibody; autophagy; metastasis; p62

Mesh:

Substances:

Year:  2020        PMID: 32329689     DOI: 10.2174/1568009620666200424145122

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  6 in total

1.  A Balance Between Autophagy and Other Cell Death Modalities in Cancer.

Authors:  Anna S Gorbunova; Gelina S Kopeina; Boris Zhivotovsky
Journal:  Methods Mol Biol       Date:  2022

2.  PINK1 Overexpression Promotes Cell Migration and Proliferation via Regulation of Autophagy and Predicts a Poor Prognosis in Lung Cancer Cases.

Authors:  Xiao Lu; Quan-Xing Liu; Jiao Zhang; Dong Zhou; Gui-Xue Yang; Man-Yuan Li; Yuan Qiu; Qian Chen; Hong Zheng; Ji-Gang Dai
Journal:  Cancer Manag Res       Date:  2020-08-24       Impact factor: 3.989

Review 3.  p62: Friend or Foe? Evidences for OncoJanus and NeuroJanus Roles.

Authors:  Sonia Emanuele; Marianna Lauricella; Antonella D'Anneo; Daniela Carlisi; Anna De Blasio; Diana Di Liberto; Michela Giuliano
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

4.  Bioinformatics Analysis of Autophagy and Mitophagy Markers Associated with Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage.

Authors:  Dong Hyuk Youn; Bong Jun Kim; Eun Pyo Hong; Jin Pyeong Jeon
Journal:  J Korean Neurosurg Soc       Date:  2021-12-23

5.  Proteomics analysis: inhibiting the expression of P62 protein by chloroquine combined with dacarbazine can reduce the malignant progression of uveal melanoma.

Authors:  Xifeng Fei; Xiangtong Xie; Ruwei Qin; Anqi Wang; Xuan Meng; Fei Sun; Yifan Zhao; Dongyi Jiang; Hanchun Chen; Qiang Huang; Xiaoyan Ji; Zhimin Wang
Journal:  BMC Cancer       Date:  2022-04-14       Impact factor: 4.430

6.  p62 Overexpression Promotes Bone Metastasis of Lung Adenocarcinoma out of LC3-Dependent Autophagy.

Authors:  Dongqi Li; Chuanchun He; Fan Ye; En Ye; Hao He; Gong Chen; Jing Zhang
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.